Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epiduo Pretreatment for Gold Microparticle Delivery
NCT03573115Completed
- Start
- Jan 2018
- Primary completion
- Jul 2018
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of adapalene + benzoyl peroxide in acne vulgaris. Primary endpoint: Change in gold microparticle delivery after 6 weeks of pretreatment evaluated by Reflectance Confocal Microscopy. Started Jan 2018; status: completed.
02
Drugs
adapalene + benzoyl peroxide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT03573115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03573115.